Cargando…
Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial
Background: This study was conducted to evaluate the safety and tolerability, and population pharmacokinetics (PPK) of montelukast as well as efficacy in the treatment of perennial allergic rhinitis (PAR) in paediatric Japanese patients aged between 1 and 15 years. Methods: In this multi-centre, ope...
Autores principales: | Okubo, Kimihiro, Inoue, Yoichi, Numaguchi, Hirotaka, Tanaka, Kumi, Saito, Itori, Oshima, Nobuyuki, Matsumoto, Yuki, Prohn, Marita, Mehta, Anish, Nishida, Chisato, Philip, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040008/ https://www.ncbi.nlm.nih.gov/pubmed/27785374 http://dx.doi.org/10.1080/21556660.2016.1209507 |
Ejemplares similares
-
Evaluation of Montelukast for the Treatment of Children With Japanese
Cedar Pollinosis Using an Artificial Exposure Chamber (OHIO
Chamber)
por: Hashiguchi, Kazuhiro, et al.
Publicado: (2018) -
Montelukast in the management of allergic rhinitis
por: Lagos, Jaime A, et al.
Publicado: (2007) -
Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis
por: Mayoral, Karina, et al.
Publicado: (2023) -
Role of Montelukast in Asthma and Allergic rhinitis patients
por: Zuberi, Faisal Faiyaz, et al.
Publicado: (2020) -
Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial
por: Okubo, Kimihiro, et al.
Publicado: (2019)